Ro (@ro) header
Ro (@ro) profile picture

Building a patient-centric healthcare system.

New York, NY
Joined September 2018
Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)
Our @ro patients asked for better dose logging. Here it is. Log the time, the site, and which side. Or just the time, if you’re on a GLP-1 pill. See every dose you’ve ever taken in one place.
4
9
2
56
5,145
Time to connect the dots – Jan 2027! @ro
3
9
1
27
3,303
.@Ro has launched a new GLP-1 pill in partnership with Novo Nordisk. CEO @ZReitano on how the pill will "usher in a new era of digital health": "It's the first time a drug of this size and scale launches nationwide on Ro, so someone can see an ad and go from diagnosis to delivery in 48 hours or less."
1
3
12
10,516
Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview. today.com/health/womens-heal…
11
35
123
86
247,882
Affordability = access. By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-approved Wegovy® for $199 plus their first month of the Ro Body membership for just $45.
3
8
2
33
32,255
Some *BIG* news from the team @ro today — we're thrilled to announce a new partnership with the one and only Charles Barkley! 🏀 As we got to know Charles through this process, it became clear how personally meaningful this subject is to him — even beyond his own weight loss journey. Charles has seen firsthand how powerful GLP-1 therapies can be as a tool for improving health, and he’s passionate about increasing awareness and access to these treatments, especially in underserved communities. We're proud to support Charles on his own health journey and to share his story — along with his signature humor and candor — through this partnership. Huge thanks to the many talented colleagues and partners involved in bring this incredible collaboration to life. We’re just getting started!
4
3
2
30
27,167
A new deal between @Ro and $NVO allows patients to get its flagship weight loss drug Wegovy for as low as $499 per month CEO @ZReitano breaks down the details of the deal and what it means for patients cnb.cx/4jvFofs
3
11
23
26,494
Today, @ro is announcing a collaboration with @novonordisk — starting with an integration with NovoCare® Pharmacy. Fighting for patients means making it as easy and affordable as possible to access high-quality treatment, and that’s what Ro and Novo aim to do.
4
3
2
36
29,586
$LLY lowering the price of the vials! $349 for 2.5 and $499 for higher doses on monthly orders. Big win for patients! Also… they’re in stock (always have been since launch). Proud to offer seamless access via @Ro in unique integration with @EliLillyandCo
8
6
3
34
64,341
1/ @Ro is empowering patients and providers with world class technology to achieve life-changing outcomes. endpts.com/ros-weight-loss-b… ➡️ Avg weight loss: 15.8% after 12 months on GLP-1s ➡️ 80% of patients with metabolic risks improved their lab results
6
8
45
54,031
Catch @Ro CEO @ZReitano at in conversation with @danprimack at #AxiosBFD in New York. Tune in tomorrow at 2:50pm ET
1
4
10
44,434
Checking GLP-1 drug insurance coverage just got a little easier, thanks to a new tool from @ro. CEO @ZReitano explains how it works. He also gives his read on the blockbuster obesity drug market.
3
7
4
28
57,436
GLP-1 drugs are in short supply, but a new supply tracker could help patients find what they need @Ro CEO and Co-Founder @ZReitano breaks down his company's newest tracker and how producers like $LLY and $NVO are handling supply and distribution obstacles:
5
18
1
54
36,444